Aug 28, 2020 — 3 min read
August 27, 2020 - Lunit (lunit.io), a South Korean medical AI software company, announced a partnership with Emergent Connect (www.emergentconnect.com), a leading provider of cloud-based PACS software. This partnership will bring AI solutions to Emergent Connect’s imaging cloud customer base, allowing AI to be more easily accessible to its clients.
Emergent Connect manages millions of imaging records per year and helps thousands of healthcare professionals across hospitals, imaging centers and clinics provide the best patient care possible. Through this collaboration, healthcare centers using Emergent Connect software will be able to experience cutting-edge AI solutions without additional installation or configuration.
Lunit is an AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers via deep learning technology. The company’s solution is embedded in imaging devices and PACS systems of major vendors such as Fujifilm and GE Healthcare, reaching around 40% of global X-ray market share. This is the first time Lunit is collaborating with an online cloud-based PACS company.
“We are excited to partner with the Lunit team and to execute on the vision of providing our clients with the very best workflow around AI over our cloud based solutions. The prospect of running Lunit’s solutions on our medical exams is an exciting opportunity for both our radiologists as well as the patients we serve across the country”, says Mike Spears, co-founder & EVP of Emergent Connect.
“It is a great pleasure to reach more healthcare professionals by expanding our portfolio from traditional PACS to cloud-based software as well,” said Brandon Suh, CEO of Lunit. “As a global partner of Emergent Connect, we will continue developing our technology to provide AI solutions that open a new era of data-driven precision medicine.”
With AI, Lunit aims to make data-driven medicine the new standard of care. We are especially focused on conquering cancer, one of the leading causes of death worldwide. We develop AI solutions for precision diagnostics and therapeutics, to find the right diagnosis at the right cost, and the right treatment for the right patients.
Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Our technology has been recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft. Lunit is headquartered in Seoul, South Korea with offices and representatives in the U.S.A., Netherlands, and China.
Founded in 2011, Emergent Connect provides 100% cloud-based software solutions for the Healthcare Industry. We specialize in Radiology solutions that are designed and built to support a small, single urgent care business through a large regional hospital chain.
In 2012, Emergent Connect launched its first PACS & RIS solution exclusively through a partnership with a national teleradiology service provider. Shortly thereafter, Emergent Connect began a journey that would later lead the company to take on additional challenges of addressing other technology shortcomings within the radiology industry.
The grand vision of connecting our customers to a 100% cloud-based architecture accelerated the company’s success and served a rapidly growing customer base with unique radiology solutions that no other company could offer. Today, Emergent Connect manages millions of records and helps thousands of healthcare professionals provide the very best patient care possible.
Lunit wins Tumor Proliferation Assessment Challenge (TUPAC) 2016
Lunit to unveil data-driven imaging biomarker at RSNA 2016
Lunit to showcase AI-powered products at USCAP 2017
Lunit INSIGHT: The First-ever, Real-time Imaging AI Analytics on the Web
Cognitive biases and augmented intelligence in radiology
Lunit Returns to RSNA with Real-time Imaging Platform, Featuring Cloud-based A
Lunit Unveils “Lunit INSIGHT,” A New Real-time Imaging AI Platform on the Web at RSNA 2017
Lunit INSIGHT: Q&A with Brandon B. Suh, Chief Medical Officer at Lunit
ANNOUNCING: BRANDON SUH, OUR NEW CEO
Lunit preps Korean IPO led by NH Investment Bank
Media Advisory: Lunit at RSNA 2018
Lunit Opens “Lunit INSIGHT for Mammography” for Public Access
Lunit Brings its Newest AI Solution for Mammography to RSNA 2018
Lunit Partners with Fujifilm and Salud Digna to Provide Medical AI Solution in Mexico
Lunit announces new members in its advisory board: Dr. Eliot Siegel, Dr. Linda Moy, and Dr. Khan Siddiqui
Lunit to Introduce Medical AI Solutions at GTC 2019
Lunit to Present Abstracts on AI-powered Precision Pathology at 2019 AACR Annual Meeting
Lunit to Showcase AI Solution for Breast Cancer at SBI 2019
Lunit to Present Findings on the Predictive Power of AI Biomarker for Lung Cancer Immunotherapy at ASCO 2019
Lunit Receives Korea MFDS Approval for its AI Solution for Breast Cancer, Lunit INSIGHT MMG
Lunit Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Lunit Gets Korea MFDS Approval for its AI Solution for Chest X-ray, Lunit INSIGHT CXR 2
Lunit at RSNA 2019
Lunit Announces its First CE Mark for AI-Powered Chest X-ray Analysis Software, Lunit INSIGHT CXR
Lunit AI software clinically installed in global sites—to be presented at RSNA 2019
Lunit Secures $26M in Series C Funding Round, Led by Asian Investors
AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall
Renowned Oncologist Dr. Tony Mok Joins Lunit Advisory Board
Lunit Releases Its AI Online to Support Healthcare Professionals Manage COVID-19
Lunit to Present Findings on the Predictive Power of AI-based Analysis of Immune Phenotype at ASCO 2020
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
AI Solution for COVID-19, Developed by Medical AI Firm Lunit, Now Has Users in More Than 10 Countries
Lunit Awarded as Technology Pioneer by World Economic Forum
Lunit at ECR 2020: Providing Virtual Exhibition and Online Presentations
Lunit Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs
AI has Added Value in Insurance Underwriting Process, Recent Pilot Project Between Lunit and Cathay Financial Innovation Lab Reveals
RSNA 2020--Lunit Collaborates with Global Giants in Presenting its AI Solution at Virtual Booths of GE Healthcare, FujiFilm, and Sectra
AI Proves Its Value in Assistance for Emergency Cases-- With Higher Accuracy and Timely Reporting Time of Chest Radiographs
Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry
AI Can Offer Fast and Reliable Examination to Triage COVID-19 Patients-- A Multicenter Retrospective Study Reveals
Recent Studies Reveal High Performance of Lunit AI in Breast Cancer Detection
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
What do the medical journals say about AI-powered mammography?
Research Using Lunit Demo Website
Lunit Presents AI-powered Pathologic Classification of Immune Phenotype that Predicts Response to Immunotherapy at USCAP 2021
What do the medical journals say about AI-powered chest x-ray interpretation?
Join our webinar with Dr. Fredrik Strand
From retrospective to prospective trials of AI in breast cancer screening
AACR 2021 - Lunit Presents Abstracts Demonstrating the Potential of its AI Biomarker in Cancer Treatment
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
Case of the Month | Where Is Breast Cancer?